Temozolomideacid
Temozolomideacid Basic information
- Product Name:
- Temozolomideacid
- Synonyms:
-
- 3-Methyl-4-oxo-8-imidazolo[5,1-d][1,2,3,5]tetrazinecarboxylic acid
- Temozolomide-8-carboxylic acid
- 3,4-Dihydro-3-Methyl-4-oxo-iMidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxylic Acid
- teMozoloMide acid 97%
- 3-Methyl-4-oxo-3,4-dihydroiMidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid
- Temozolomideacid
- Temozolomide Impurity 1
- Temozolomide Impurity C
- CAS:
- 113942-30-6
- MF:
- C6H5N5O3
- MW:
- 195.14
- Product Categories:
-
- Bases & Related Reagents
- Heterocycles
- Intermediates & Fine Chemicals
- Metabolites & Impurities
- Nucleotides
- Pharmaceuticals
- Mol File:
- 113942-30-6.mol
Temozolomideacid Chemical Properties
- Melting point:
- 166-168°C
- Boiling point:
- 487.7±37.0 °C(Predicted)
- Density
- 1.97±0.1 g/cm3(Predicted)
- storage temp.
- Inert atmosphere,2-8°C
- solubility
- DMSO (Slightly), Methanol (Slightly)
- pka
- 2.88±0.20(Predicted)
- form
- Solid
- color
- White to Off-White
- Stability:
- Hygroscopic
Temozolomideacid Usage And Synthesis
Chemical Properties
White Solid
Uses
A metabolite of Temozolomide (T017775) as antitumor agent.
Synthesis
85622-93-1
113942-30-6
General procedure: Example 1 Preparation of 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid (EP0252682) 1. 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide (2.577 mmol, 0.5 g) was mixed with concentrated sulfuric acid (4 mL) under stirring conditions. 2. a solution was prepared by dissolving sodium nitrite (9.4 mmol, 0.65 g) in 2.6 mL of water. 3. Slowly add the aqueous sodium nitrite solution dropwise to the above mixture under cooling in an ice bath (keeping the temperature below 15°C). 4. After the dropwise addition, the reaction mixture was stirred at room temperature overnight. 5. 10 g of ice was added to the reaction mixture and cooling was continued in an ice bath for 1 hour. 6. The solid product was collected by filtration. 7. The collected solid product was dried under vacuum to give 0.493 g of 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid. The yield was 98.6%.
References
[1] European Journal of Medicinal Chemistry, 2002, vol. 37, # 4, p. 323 - 332
[2] Patent: EP1798234, 2007, A1. Location in patent: Page/Page column 11
[3] Patent: US2018/79754, 2018, A1. Location in patent: Paragraph 0082; 0101-0102
[4] European Journal of Medicinal Chemistry, 2017, vol. 127, p. 691 - 702
[5] Journal of Medicinal Chemistry, 2002, vol. 45, # 25, p. 5458 - 5470
TemozolomideacidSupplier
- Tel
- 17316404525 17316404525
- 209533805@qq.com
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 17702719238 18971495150;
- sales@sun-shinechem.com
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 0510-83588313-811 18800520310
- sales@chemshuttle.com
Temozolomideacid(113942-30-6)Related Product Information
- TeMozoloMide Metabolite - MTIC
- 3-Amino-2-(formylamino)-3-iminopropanamide
- Temozolomide
- 5-Amino-4-imidazolecarboxamide
- Cyano temozolomide
- 4-diazo-4H-imidazole-5-carboxamide
- Ulipristal acetate InterMediate
- 1,5-dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one
- 1H-Imidazole-4-carboxamide,5-(methylamino)-(9CI)
- Cyanotemozolomide
- 5-(Amino-1-(N-methyl Carbamoyl)
- 4-diazoimidazole-5-carboxamide